Home » Healthcare » Canada Periodontal Disease Market

Canada Periodontal Disease Market By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, Type 5); By Application (Non-surgical Treatment, Surgical Treatment, Application 3, Application 4, Application 5); By Therapeutics (Systematic Antibiotics, Local Antibiotics, Therapeutics 3, Therapeutics 4, Therapeutics 5); By End Users (Hospitals, Dental Clinics, Dental Academics); By Distribution Channel (Distribution Channel 1, Distribution Channel 2, Distribution Channel 3, Distribution Channel 4, Distribution Channel 5) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Canada Periodontal Disease Market Size 2024	USD 141.39 million
Canada Periodontal Disease Market, CAGR	5.09%
Canada Periodontal Disease Market Size 2032	USD 225.20 million

Market Overview

The Canada periodontal disease market is projected to grow from USD 141.39 million in 2023 to USD 225.20 million by 2032, registering a compound annual growth rate (CAGR) of 5.09% during the forecast period.

The Canada periodontal disease market is driven by the rising prevalence of periodontal disorders, fueled by an aging population and increasing awareness of oral health’s impact on overall well-being. Advancements in diagnostic technologies and treatment options, such as minimally invasive procedures and regenerative therapies, further support market growth. The increasing adoption of dental insurance plans and government initiatives to enhance oral healthcare access also contribute to the market’s expansion. Additionally, growing consumer preference for aesthetic dental solutions drives demand for innovative treatments. Key trends include the integration of artificial intelligence in diagnostic tools and personalized treatment plans, enabling early detection and efficient management of periodontal diseases. Collaboration among dental professionals, researchers, and technology providers is fostering innovation in the field. This dynamic combination of factors positions the market for significant growth, meeting the evolving needs of patients and professionals in Canada’s dental care sector.

The geographical analysis of the Canada periodontal disease market highlights regional variations in access to dental care and the adoption of advanced treatments. Urban regions like Ontario and Quebec are leading due to their well-established healthcare infrastructure, high concentration of dental professionals, and increased awareness of oral health. In contrast, rural and remote areas face challenges such as limited access to specialized periodontal care and a shortage of trained periodontists. However, initiatives like tele-dentistry and mobile clinics are addressing these disparities. Key players driving the market include Bausch Health Companies Inc., Colgate-Palmolive Company, DENTSPLY SIRONA Inc., and Biolase, Inc., among others. These companies are focused on technological advancements, innovative treatment methods, and expanding their presence across underserved areas. Their efforts, combined with public and private initiatives, are shaping the market, improving access to quality care, and promoting better oral health outcomes nationwide.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Canada periodontal disease market is valued at USD 141.39 million in 2023 and is projected to reach USD 225.20 million by 2032, with a CAGR of 5.09%.
Rising awareness of the link between periodontal disease and systemic health is boosting market growth.
The increasing aging population in Canada is contributing to higher cases of periodontal disease, creating demand for specialized treatments.
Unhealthy lifestyle factors, such as smoking and poor diet, are significant drivers for the rising prevalence of periodontal conditions.
High treatment costs and limited insurance coverage remain key barriers, limiting accessibility to care.
Rural areas in Canada face challenges such as a shortage of periodontists, hindering access to specialized treatments.
Ontario and Quebec lead the market due to their well-established healthcare systems, while rural areas benefit from emerging tele-dentistry solutions.

Market Drivers

Rising Prevalence of Periodontal Disease

The increasing incidence of periodontal disease in Canada is largely attributed to an aging population, as older individuals are more susceptible to gum-related issues. Poor oral hygiene practices, including irregular brushing and flossing, contribute significantly to the onset and progression of this condition. For instance, a survey by the Canadian Dental Association highlights that older adults are more likely to experience severe periodontal issues due to these combined factors. Additionally, unhealthy lifestyle factors such as smoking, excessive alcohol consumption, and poor dietary habits further exacerbate the prevalence of periodontal disease. Systemic diseases, including diabetes, heart disease, and respiratory conditions, are also linked to periodontal health, often worsening symptoms and complicating treatment outcomes. Together, these factors underline the need for comprehensive prevention and management strategies.

Increased Awareness and Early Detection

Enhanced public awareness of periodontal health, driven by government initiatives and campaigns from dental associations, has significantly improved early detection rates. Public health campaigns emphasize the importance of oral hygiene and highlight the risks associated with untreated periodontal disease. For instance, Health Canada’s “Healthy Smiles” campaign has been instrumental in educating the public about the importance of regular dental check-ups. Technological advancements, including intraoral cameras and digital X-rays, have revolutionized early diagnosis, enabling dental professionals to detect periodontal issues more accurately and at earlier stages. These developments empower both patients and practitioners to address the condition proactively, reducing its long-term impact on overall health.

Growing Demand for Aesthetic Dentistry

The rising societal focus on appearance and self-confidence has spurred demand for aesthetic dental procedures, including those addressing periodontal concerns. Social and professional pressures are encouraging individuals to seek cosmetic treatments such as gum contouring, which enhance both functionality and aesthetics. For instance, a report by the Canadian Dental Association notes a significant increase in the number of patients seeking cosmetic periodontal treatments, positioning it as a vital segment in the dental industry. This growing interest in aesthetic dentistry reflects changing consumer preferences and highlights the convergence of periodontal care with cosmetic advancements, positioning it as a vital segment in the dental industry.

Government Policies and Technological Advancements

Supportive government initiatives and favorable healthcare policies are further driving the market. Publicly funded dental insurance programs enhance access to periodontal care, particularly for low-income groups, while reimbursement policies incentivize providers to offer specialized treatments. For example, the Ontario Health Insurance Plan (OHIP) includes coverage for certain periodontal treatments, making them more accessible to a broader population. Technological innovations, such as minimally invasive laser therapies and regenerative techniques like tissue engineering, are transforming periodontal treatment. These advancements improve patient outcomes and underscore the growing importance of specialized care provided by periodontists, addressing complex cases with cutting-edge solutions.

Market Trends

Advancing Awareness and Demand for Aesthetic Dentistry

Rising awareness of periodontal disease, driven by public health campaigns and technological advancements, has significantly improved early detection and treatment. Educational initiatives from government bodies and dental associations emphasize the importance of oral health and highlight the risks of untreated gum disease. These campaigns are complemented by advanced diagnostic tools, such as intraoral cameras and digital X-rays, which enhance the accuracy and timeliness of periodontal disease detection. Meanwhile, the growing societal focus on appearance and self-confidence has led to increased demand for aesthetic dental solutions. Procedures like gum contouring and regenerative treatments not only restore oral health but also address cosmetic concerns, aligning with consumer preferences for holistic care. The integration of periodontal and aesthetic treatments underscores the evolution of dental care, catering to both functional and cosmetic needs.

Technological Innovations and Supportive Healthcare Policies

Technological advancements and government policies are playing pivotal roles in shaping the periodontal disease market. Cutting-edge treatments, such as laser therapy, offer minimally invasive options that improve patient comfort and treatment efficacy. Similarly, regenerative dentistry, including tissue engineering and stem cell therapy, holds promise for repairing and restoring gum tissue, advancing the standard of care. On the policy front, government-funded dental insurance programs have expanded access to periodontal care, particularly for underserved populations. For example, the Canadian Dental Care Plan (CDCP) provides coverage for various dental services, making them more accessible to eligible residents. Favorable reimbursement frameworks further incentivize healthcare providers to adopt innovative treatment methods. Additionally, the growing complexity of periodontal cases has led to increased demand for specialized care, highlighting the critical role of periodontists in delivering tailored and effective treatments. Together, these trends reflect a market poised for growth, driven by innovation and policies that prioritize accessibility and quality.

Market Challenges Analysis

High Treatment Costs and Limited Access to Specialized Care

The high cost of periodontal treatments presents a significant challenge for many Canadians. Advanced procedures, such as periodontal surgery and dental implant placement, are often expensive, making them inaccessible to a large segment of the population. For instance, surgical treatments like soft tissue grafts can range from CAD $800 to $1,600 per tooth, and bone grafting procedures can cost anywhere from CAD $300 to $1,600 per site. This issue is compounded by the lack of comprehensive dental insurance coverage, leaving patients to bear substantial out-of-pocket expenses. Additionally, access to specialized care remains a critical issue, particularly in rural and remote areas where there is a shortage of qualified periodontists. This shortage not only limits the availability of expert care but also results in long wait times for patients requiring specialized periodontal treatments. These barriers hinder timely diagnosis and effective treatment, potentially worsening patient outcomes and increasing the burden of oral health issues across the country.

Awareness Gaps, Regulatory Barriers, and Economic Constraints

Low awareness levels about periodontal disease and its systemic health implications further exacerbate challenges in this market. Many individuals fail to recognize the importance of proper oral hygiene and its role in preventing gum disease. Additionally, the lack of understanding about the connection between periodontal health and conditions like diabetes and heart disease often leads to poor compliance with treatment protocols. Regulatory hurdles also pose significant challenges, as Canada’s stringent approval processes can delay the introduction of innovative treatments and technologies, slowing market growth. Economic factors, such as downturns, further impact the market, reducing consumer spending on non-emergency dental care, including periodontal treatments. Together, these challenges create a complex environment that demands strategic interventions to improve awareness, accessibility, and affordability, ensuring better oral health outcomes for Canadians.

Market Opportunities

Expanding Access and Growing Demand for Advanced Treatments

The Canada periodontal disease market presents significant opportunities to improve access to care through expanded dental insurance coverage and government-funded programs. As policymakers increasingly recognize the impact of oral health on overall well-being, initiatives aimed at subsidizing treatment costs could enhance affordability, particularly for underserved populations. Tele-dentistry and mobile clinics also offer innovative solutions to address access challenges in remote and rural areas, connecting patients with specialized care. Furthermore, the growing emphasis on early detection and preventive measures creates opportunities for dental professionals to adopt advanced diagnostic tools, such as digital imaging and AI-based assessment technologies. These advancements not only improve patient outcomes but also streamline workflows for practitioners, driving market expansion.

Innovations in Aesthetic and Regenerative Dentistry

The rising demand for aesthetic dentistry, driven by social and professional pressures, provides a lucrative opportunity for periodontal care providers to offer integrated solutions that combine health and cosmetic benefits. Advanced treatments like laser therapy and regenerative techniques, including tissue engineering and stem cell therapy, are increasingly sought after for their minimally invasive nature and superior outcomes. Additionally, collaborations between dental professionals, technology providers, and research institutions can accelerate innovation, bringing cutting-edge solutions to market. As consumer awareness about the importance of periodontal health continues to grow, investments in education campaigns and training programs for specialists will further strengthen the industry, positioning it to meet the evolving needs of patients across Canada.

Market Segmentation Analysis:

By Type:

The Canada periodontal disease market is segmented by type into gingivitis, chronic periodontal disease, aggressive periodontal disease, type 4, and type 5. Among these, chronic periodontal disease holds a significant share due to its high prevalence, particularly among middle-aged and elderly populations. Gingivitis, the mildest form of periodontal disease, is widespread and often serves as a precursor to more severe conditions if left untreated. Aggressive periodontal disease, though less common, poses challenges due to its rapid progression and the necessity for specialized treatment. Emerging focus on types 4 and 5, potentially encompassing systemic or advanced stages, reflects evolving classifications in line with modern diagnostic and treatment advancements. This segmentation enables targeted approaches to address varying severity levels, enhancing the efficacy of treatment options.

By Application:

Segmentation by application includes non-surgical treatments, surgical treatments, application 3, application 4, and application 5. Non-surgical treatments, such as scaling and root planing, dominate the segment due to their effectiveness in managing early-stage periodontal disease. Surgical treatments, including flap surgery and regenerative procedures, are gaining traction for addressing advanced cases with complex requirements. Applications 3, 4, and 5 likely encompass specialized or emerging therapeutic approaches that cater to niche market demands. This segmentation highlights the growing emphasis on personalized and stage-specific treatment strategies, supported by advancements in minimally invasive techniques and regenerative therapies, driving innovation and improved patient outcomes in the Canadian market.

Segments:

Based on Type:

Gingivitis
Chronic Periodontal Disease
Aggressive Periodontal Disease
Type 4
Type 5

Based on Application:

Non-surgical Treatment
Surgical Treatment
Application 3
Application 4
Application 5

Based on Therapeutics:

Systematic Antibiotics
Local Antibiotics
Therapeutics 3
Therapeutics 4
Therapeutics 5

Based on End Users:

Hospitals
Dental Clinic
Dental Academics

Based on Distribution Channel:

Distribution Channel 1
Distribution Channel 2
Distribution Channel 3
Distribution Channel 4
Distribution Channel 5

Based on the Geography:

Ontario
Quebec
Western Canada
British Columbia
Atlantic Canada

Regional Analysis

Ontario

Ontario holds the largest share in the Canada periodontal disease market, accounting for over 35% of the total market revenue in 2023. This dominance is attributed to its dense population, well-established healthcare infrastructure, and a high number of dental professionals offering specialized periodontal care. The region benefits from increased awareness initiatives and government-supported dental insurance programs, ensuring broader access to treatment. Ontario’s urban centers, such as Toronto and Ottawa, drive demand for both preventive and advanced periodontal care, fueled by heightened awareness of oral health’s role in overall well-being. Additionally, the adoption of advanced technologies, such as laser treatments and AI-driven diagnostics, has enhanced patient outcomes and improved care efficiency. The demand for aesthetic dentistry, particularly in urban areas, further propels growth as consumers seek solutions for both health and cosmetic concerns. Continued investment in healthcare infrastructure and training programs for periodontists is expected to solidify Ontario’s leadership in the market.

Western Canada

Western Canada, comprising Alberta, Saskatchewan, and Manitoba, captures approximately 20% of the market share, making it a growing region in the periodontal disease market. The region’s growth is driven by increasing awareness campaigns and rising adoption of advanced periodontal treatments. Rural areas in Western Canada present unique challenges due to limited access to specialized care and a shortage of periodontists. However, tele-dentistry initiatives and mobile dental clinics are beginning to bridge these gaps, ensuring that underserved communities receive timely treatment. Alberta, in particular, is emerging as a key contributor, with its robust healthcare infrastructure and a growing number of dental clinics adopting innovative technologies like regenerative therapies and minimally invasive surgical procedures. Public-private partnerships aimed at enhancing dental care access are further strengthening the market’s foothold in Western Canada. As awareness about the systemic implications of periodontal health rises, the demand for comprehensive care is expected to grow, positioning this region as a promising market for future investments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Bausch Health Companies Inc
Colgate-Palmolive Company
Mylan N.V.
Lyne Laboratories
WOCKHARDT
DENTSPLY SIRONA Inc
3M
Amyndas Pharmaceuticals
Biolase, Inc
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of the Canada periodontal disease market is driven by a mix of established global companies and specialized dental care providers. Leading players in the market include Bausch Health Companies Inc., Colgate-Palmolive Company, Mylan N.V., Lyne Laboratories, WOCKHARDT, DENTSPLY SIRONA Inc., 3M, Amyndas Pharmaceuticals, Biolase, Inc., and others. These companies offer a wide range of periodontal care solutions, including advanced treatment devices, diagnostic tools, and oral hygiene products. These companies compete by offering a variety of periodontal care solutions, including diagnostic tools, advanced treatment options, and oral hygiene products. Leading players differentiate themselves through technological innovation, such as laser therapy and digital diagnostics, which improve treatment outcomes and patient experiences. In addition, companies focus on expanding their market reach by partnering with dental professionals and healthcare providers. They are also increasingly investing in patient education and awareness campaigns to promote the importance of oral health and early detection of periodontal disease. As the demand for advanced periodontal care continues to rise, competition is expected to intensify, with key players seeking to strengthen their product portfolios and improve access to care, particularly in underserved rural and remote regions. The emphasis on non-invasive and minimally painful treatments also drives innovation in the market, presenting new opportunities for growth and improved patient outcomes.

Recent Developments

In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
In June 2023, Eli Lilly and Company finalized an agreement to acquire DICE Therapeutics, Inc., a renowned biopharmaceutical firm recognized for its groundbreaking DELSCAPE technology platform. This platform is instrumental in creating novel oral therapeutic candidates, such as oral IL-17 inhibitors, which are presently in clinical development. These treatments are designed to target chronic immune-related diseases.
In March 2023, Haleon initiated the #BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
In February 2022, Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.

Market Concentration & Characteristics

The market concentration of the Canada periodontal disease sector is moderate, with a mix of global players and regional specialists. While global companies dominate the market in terms of product variety and reach, regional players are increasingly becoming significant contenders by offering specialized services and localized solutions. Large-scale dental product manufacturers focus on oral hygiene products, diagnostics, and treatment technologies, establishing a broad customer base across Canada’s urban and rural regions. In contrast, specialized periodontal clinics and smaller companies focus on delivering personalized care, advanced treatments like laser therapies, and offering expertise in complex periodontal conditions. Market characteristics highlight a growing emphasis on technological advancements and minimally invasive procedures, driving innovation and better patient outcomes. Non-surgical treatments, such as scaling and root planing, continue to be the primary care option for most cases, but the market is witnessing a shift toward surgical interventions in more advanced cases. Increasing awareness of the importance of oral health and its systemic connection to overall well-being is further expanding the market. Additionally, as more patients seek cosmetic dental procedures, such as gum contouring, the market is witnessing a higher demand for aesthetic periodontal treatments. This trend is expected to drive further growth in the market, with continued innovations in both treatment methods and patient care solutions.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, Therapeutics, End Users, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Canada periodontal disease market is expected to grow steadily, driven by an aging population and rising awareness of oral health.
Advances in diagnostic technologies, such as digital X-rays and intraoral cameras, will enable earlier detection and more accurate treatment.
The demand for minimally invasive treatments, like laser therapy, is anticipated to increase, improving patient comfort and recovery times.
Growing interest in aesthetic dental procedures, such as gum contouring, will contribute to the market’s expansion.
Public health campaigns and education on the connection between oral health and systemic conditions will drive increased patient engagement and treatment adoption.
Access to periodontal care in rural and remote areas will improve with the rise of tele-dentistry and mobile dental clinics.
Government initiatives, including dental insurance programs and favorable reimbursement policies, will enhance access to care for low-income individuals.
Increased investment in regenerative dental technologies, including stem cell therapies, will open new avenues for treating advanced periodontal disease.
As more patients seek specialized care, the demand for trained periodontists will rise, driving the need for education and training in the field.
Competitive pressure among key players will spur innovation, resulting in the development of more effective, cost-efficient treatments for periodontal disease.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. PERIODONTAL DISEASE Market Snapshot 21

2.1.1. Canada PERIODONTAL DISEASE Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERIODONTAL DISEASE MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Driving Factor 1 Analysis 25

4.2.2. Driving Factor 2 Analysis 26

4.3. Market Restraints 27

4.3.1. Restraining Factor Analysis 27

4.4. Market Opportunities 28

4.4.1. Market Opportunity Analysis 28

4.5. Porter’s Five Forces Analysis 29

4.6. Value Chain Analysis 30

4.7. Buying Criteria 31

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 32

5.1. Import Analysis by Canada 32

5.1.1. Canada PERIODONTAL DISEASE Market Import Volume/Revenue, By Canada, 2018 – 2023 32

5.2. Export Analysis by Canada 33

5.2.1. Canada PERIODONTAL DISEASE Market Export Volume/Revenue, By Canada, 2018 – 2023 33

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 34

6.1. Demand Analysis by Canada 34

6.1.1. Canada PERIODONTAL DISEASE Market Demand Volume/Revenue, By Canada, 2018 – 2023 34

6.2. Supply Analysis by Canada 35

6.2.1. Canada PERIODONTAL DISEASE Market Supply Volume/Revenue, By Canada, 2018 – 2023 35

CHAPTER NO. 7 : PRODUCTION ANALYSIS 36

7.1. Production Analysis by Canada 36

7.1.1. Canada PERIODONTAL DISEASE Market Production Volume/Revenue, By Canada, 2018 – 2023 36

CHAPTER NO. 8 : PRICE ANALYSIS 37

8.1. Price Analysis by Type 37

8.1.1. Canada PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 37

8.1.2. Canada Type Market Price, By Type, 2018 – 2023 37

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 38

9.1. Key Raw Materials and Suppliers 38

9.2. Key Raw Materials Price Trend 38

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 39

10.1. Manufacturing Cost Analysis 39

10.2. Manufacturing Process 39

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 40

11.1. Company Market Share Analysis – 2023 40

11.1.1. Canada PERIODONTAL DISEASE Market: Company Market Share, by Volume, 2023 40

11.1.2. Canada PERIODONTAL DISEASE Market: Company Market Share, by Revenue, 2023 41

11.1.3. Canada PERIODONTAL DISEASE Market: Top 6 Company Market Share, by Revenue, 2023 41

11.1.4. Canada PERIODONTAL DISEASE Market: Top 3 Company Market Share, by Revenue, 2023 42

11.2. Canada PERIODONTAL DISEASE Market Company Volume Market Share, 2023 43

11.3. Canada PERIODONTAL DISEASE Market Company Revenue Market Share, 2023 44

11.4. Company Assessment Metrics, 2023 45

11.4.1. Stars 45

11.4.2. Emerging Leaders 45

11.4.3. Pervasive Players 45

11.4.4. Participants 45

11.5. Start-ups /SMEs Assessment Metrics, 2023 45

11.5.1. Progressive Companies 45

11.5.2. Responsive Companies 45

11.5.3. Dynamic Companies 45

11.5.4. Starting Blocks 45

11.6. Strategic Developments 46

11.6.1. Acquisitions & Mergers 46

New Product Launch 46

Canada Expansion 46

11.7. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERIODONTAL DISEASE MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. PERIODONTAL DISEASE Market Overview, by Type Segment 49

13.1.1. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Gingivitis 53

13.3. Chronic Periodontal Disease 54

13.4. Aggressive Periodontal Disease 55

13.5. Type 4 56

13.6. Type 5 57

CHAPTER NO. 14 : PERIODONTAL DISEASE MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. PERIODONTAL DISEASE Market Overview, by Application Segment 58

14.1.1. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Non-surgical Treatment 62

14.3. Surgical Treatment 63

14.4. Application 3 64

14.5. Application 4 65

14.6. Application 5 66

CHAPTER NO. 15 : PERIODONTAL DISEASE MARKET – BY THERAPEUTICS SEGMENT ANALYSIS 67

15.1. PERIODONTAL DISEASE Market Overview, by Therapeutics Segment 67

15.1.1. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 68

15.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Therapeutics 69

15.1.3. Incremental Revenue Growth Opportunity, by Therapeutics, 2024 – 2032 69

15.1.4. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 70

15.2. Systematic Antibiotics 71

15.3. Local Antibiotics 72

15.4. Therapeutics 3 73

15.5. Therapeutics 4 74

15.6. Therapeutics 5 75

CHAPTER NO. 16 : PERIODONTAL DISEASE MARKET – BY END USERS SEGMENT ANALYSIS 76

16.1. PERIODONTAL DISEASE Market Overview, by End Users Segment 76

16.1.1. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 77

16.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By End Users 78

16.1.3. Incremental Revenue Growth Opportunity, by End Users, 2024 – 2032 78

16.1.4. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 79

16.2. Hospitals 80

16.3. Dental Clinic 81

16.4. Dental Academics 82

CHAPTER NO. 17 : – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 83

17.1. PERIODONTAL DISEASE Market Overview, by Distribution Channel Segment 83

17.1.1. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 84

17.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Distribution Channel 85

17.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 85

17.1.4. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

17.2. Distribution Channel 1 87

17.3. Distribution Channel 2 88

17.4. Distribution Channel 3 89

17.5. Distribution Channel 4 90

17.6. Distribution Channel 5 91

CHAPTER NO. 18 : PERIODONTAL DISEASE MARKET – CANADA ANALYSIS 92

18.1. Type 92

18.1.1. Canada PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 92

18.2. Canada PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 92

18.3. Application 93

18.3.1. Canada PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 93

18.3.2. Canada PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 93

18.4. Therapeutics 94

18.4.1. Canada PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 94

18.4.2. Canada PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 94

18.5. End Users 95

18.5.1. Canada PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 95

18.5.2. Canada PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 95

18.6. Distribution Channel 96

18.6.1. Canada PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 96

18.6.2. Canada PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 96

CHAPTER NO. 19 : COMPANY PROFILES 97

19.1. Bausch Health Companies Inc 97

19.1.1. Company Overview 97

19.1.2. Product Portfolio 97

19.1.3. Swot Analysis 97

19.1.4. Business Strategy 98

19.1.5. Financial Overview 98

19.1.6. Colgate-Palmolive Company 99

19.1.7. Mylan N.V. 99

19.1.8. Lyne Laboratories 99

19.1.9. WOCKHARDT 99

19.1.10. DENTSPLY SIRONA Inc 99

19.1.11. 3M 99

19.1.12. Amyndas Pharmaceuticals 99

19.1.13. Biolase, Inc 99

19.1.14. Company 10 99

19.1.15. Company 11 99

19.1.16. Company 12 99

19.1.17. Company 13 99

19.1.18. Company 14 99

CHAPTER NO. 20 : RESEARCH METHODOLOGY 100

20.1. Research Methodology 100

20.1.1. Phase I – Secondary Research 101

20.1.2. Phase II – Data Modeling 101

Company Share Analysis Model 102

Revenue Based Modeling 102

20.1.3. Phase III – Primary Research 103

20.1.4. Research Limitations 104

Assumptions 104

List of Figures

FIG NO. 1. Canada PERIODONTAL DISEASE Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Canada PERIODONTAL DISEASE Market 29

FIG NO. 3. Value Chain Analysis for Canada PERIODONTAL DISEASE Market 30

FIG NO. 4. Canada PERIODONTAL DISEASE Market Import Volume/Revenue, By Canada, 2018 – 2023 32

FIG NO. 5. Canada PERIODONTAL DISEASE Market Export Volume/Revenue, By Canada, 2018 – 2023 33

FIG NO. 6. Canada PERIODONTAL DISEASE Market Demand Volume/Revenue, By Canada, 2018 – 2023 34

FIG NO. 7. Canada PERIODONTAL DISEASE Market Supply Volume/Revenue, By Canada, 2018 – 2023 35

FIG NO. 8. Canada PERIODONTAL DISEASE Market Production Volume/Revenue, By Canada, 2018 – 2023 36

FIG NO. 9. Canada PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. PERIODONTAL DISEASE Market – Company Volume Market Share, 2023 43

FIG NO. 18. PERIODONTAL DISEASE Market – Company Revenue Market Share, 2023 44

FIG NO. 19. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Canada PERIODONTAL DISEASE Market for Gingivitis, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Canada PERIODONTAL DISEASE Market for Chronic Periodontal Disease, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Canada PERIODONTAL DISEASE Market for Aggressive Periodontal Disease, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Canada PERIODONTAL DISEASE Market for Type 4, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Canada PERIODONTAL DISEASE Market for Type 5, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Canada PERIODONTAL DISEASE Market for Non-surgical Treatment, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Canada PERIODONTAL DISEASE Market for Surgical Treatment, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Canada PERIODONTAL DISEASE Market for Application 3, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Canada PERIODONTAL DISEASE Market for Application 4, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Canada PERIODONTAL DISEASE Market for Application 5, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By Therapeutics 69

FIG NO. 39. Incremental Revenue Growth Opportunity by Therapeutics, 2024 – 2032 69

FIG NO. 40. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Canada PERIODONTAL DISEASE Market for Systematic Antibiotics, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Canada PERIODONTAL DISEASE Market for Local Antibiotics, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Canada PERIODONTAL DISEASE Market for Therapeutics 3, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Canada PERIODONTAL DISEASE Market for Therapeutics 4, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Canada PERIODONTAL DISEASE Market for Therapeutics 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By End Users 78

FIG NO. 48. Incremental Revenue Growth Opportunity by End Users, 2024 – 2032 78

FIG NO. 49. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 79

FIG NO. 50. Canada PERIODONTAL DISEASE Market for Hospitals, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. Canada PERIODONTAL DISEASE Market for Dental Clinic, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. Canada PERIODONTAL DISEASE Market for Dental Academics, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. Canada PERIODONTAL DISEASE Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. Canada PERIODONTAL DISEASE Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. Canada PERIODONTAL DISEASE Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. Canada PERIODONTAL DISEASE Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. Canada PERIODONTAL DISEASE Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : Canada PERIODONTAL DISEASE Market: Snapshot 18

TABLE NO. 2. : Drivers for the PERIODONTAL DISEASE Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the PERIODONTAL DISEASE Market: Impact Analysis 24

TABLE NO. 4. : Canada PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Canada PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : Canada PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : Canada PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : Canada PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : Canada PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Canada PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Canada PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : Canada PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : Canada PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : Canada PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the Canada Periodontal Disease market?

The Canada periodontal disease market is valued at USD 141.39 million in 2023 and is projected to grow to USD 225.20 million by 2032, with a compound annual growth rate (CAGR) of 5.09%.

What factors are driving the growth of the Canada Periodontal Disease market?

Key growth drivers include an aging population, increasing awareness of oral health’s connection to overall well-being, advancements in diagnostic and treatment technologies, rising adoption of dental insurance, and growing demand for aesthetic dental solutions.

What are the key segments within the Canada Periodontal Disease market?

The market is segmented by type (e.g., Gingivitis, Chronic Periodontal Disease), application (Non-surgical and Surgical Treatments), end users (Hospitals, Dental Clinics), and geography (Ontario, Quebec, Western Canada, British Columbia, Atlantic Canada).

What are some challenges faced by the Canada Periodontal Disease market?

Challenges include high treatment costs, limited insurance coverage, a shortage of specialized periodontists in rural and remote areas, and low awareness of the systemic health implications of periodontal disease.

Who are the major players in the Canada Periodontal Disease market?

Major players include Bausch Health Companies Inc., Colgate-Palmolive Company, DENTSPLY SIRONA Inc., Biolase, Inc., and WOCKHARDT, among others. These companies focus on advanced treatments, diagnostic tools, and expanding access to care across Canada.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –